Clinical Trials Logo

Acute Mania clinical trials

View clinical trials related to Acute Mania.

Filter by:
  • None
  • Page 1

NCT ID: NCT03287869 Completed - Bipolar I Disorder Clinical Trials

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

Start date: October 24, 2017
Phase: Phase 3
Study type: Interventional

This study evaluated the safety and evaluate the safety and tolerability of open-label brexpiprazole (2 - 4 mg/day, with a starting dose of 2 mg/day) for the treatment of adult subjects with bipolar I disorder. All participants received a starting dose of brexpiprazole.

NCT ID: NCT00931723 Completed - Acute Mania Clinical Trials

Adult Bipolar Mania

Start date: June 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if lithium 600-1800 mg/day is effective when added to quetiapine fumarate extended release (quetiapine XR or SEROQUEL® XR) 400-800 mg/day in treating acute mania and if so, how it compares with placebo (a non-active capsule, like a sugar pill, that looks like lithium).

NCT ID: NCT00329108 Terminated - Clinical trials for Bipolar Disorder, Manic

Ziprasidone And Olanzapine's Outcomes In Mania

ZOOM
Start date: November 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the efficacy and tolerability of ziprasidone versus olanzapine in the treatment of acute mania. An open label extension will further evaluate the efficacy, safety, and tolerability of ziprasidone compared with olanzapine. Study recruitment was stopped due to difficulty in enrolling the targeted number of patients on July 30, 2007. Subjects that were enrolled at the time completed the study as per protocol. There were no safety concerns involved in the decision to stop enrollment. The Last Subject Last Visit was January 10, 2008.